Open Access
Frontiers in Immunology, volume 7
Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation
Ma Bin
1, 2
,
Michael O. Hottiger
3
Publication type: Journal Article
Publication date: 2016-09-22
Journal:
Frontiers in Immunology
scimago Q1
SJR: 1.868
CiteScore: 9.8
Impact factor: 5.7
ISSN: 16643224
PubMed ID:
27713747
Immunology
Immunology and Allergy
Abstract
Besides its important role in embryonic development and homeostatic self-renewal in adult tissues, Wnt/β-catenin signaling exerts both anti-inflammatory and pro-inflammatory functions. This is, at least partially, due to either repressing or enhancing the NF-κB pathway. Similarly, the NF-κB pathway either positively or negatively regulates Wnt/β-catenin signaling. Different components of the two pathways are involved in this crosstalk, forming a complex regulatory network. This review summarizes our current understanding of the molecular mechanisms underlying the cross-regulation between the two pathways and discusses their involvement in inflammation and inflammation-associated diseases such as cancer.
Found
Found
Top-30
Journals
5
10
15
20
25
|
|
International Journal of Molecular Sciences
23 publications, 5.31%
|
|
Frontiers in Immunology
11 publications, 2.54%
|
|
International Immunopharmacology
10 publications, 2.31%
|
|
Cells
9 publications, 2.08%
|
|
Biomedicine and Pharmacotherapy
8 publications, 1.85%
|
|
Cancers
7 publications, 1.62%
|
|
Biomedicines
7 publications, 1.62%
|
|
Scientific Reports
7 publications, 1.62%
|
|
Life Sciences
6 publications, 1.39%
|
|
Frontiers in Pharmacology
5 publications, 1.15%
|
|
Frontiers in Oncology
5 publications, 1.15%
|
|
Aging
4 publications, 0.92%
|
|
Nutrients
4 publications, 0.92%
|
|
Frontiers in Endocrinology
4 publications, 0.92%
|
|
Molecular Neurobiology
4 publications, 0.92%
|
|
Experimental and Therapeutic Medicine
3 publications, 0.69%
|
|
Biomolecules
3 publications, 0.69%
|
|
Frontiers in Physiology
3 publications, 0.69%
|
|
Frontiers in Neuroscience
3 publications, 0.69%
|
|
Frontiers in Cell and Developmental Biology
3 publications, 0.69%
|
|
Frontiers in Cardiovascular Medicine
3 publications, 0.69%
|
|
European Journal of Pharmacology
3 publications, 0.69%
|
|
International Journal of Biological Macromolecules
3 publications, 0.69%
|
|
Molecular Immunology
3 publications, 0.69%
|
|
Journal of Clinical Periodontology
3 publications, 0.69%
|
|
FASEB Journal
3 publications, 0.69%
|
|
Mediators of Inflammation
3 publications, 0.69%
|
|
Proceedings of the National Academy of Sciences of the United States of America
3 publications, 0.69%
|
|
Blood advances
3 publications, 0.69%
|
|
5
10
15
20
25
|
Publishers
20
40
60
80
100
120
|
|
Elsevier
109 publications, 25.17%
|
|
MDPI
69 publications, 15.94%
|
|
Frontiers Media S.A.
54 publications, 12.47%
|
|
Springer Nature
48 publications, 11.09%
|
|
Wiley
33 publications, 7.62%
|
|
Cold Spring Harbor Laboratory
16 publications, 3.7%
|
|
Taylor & Francis
10 publications, 2.31%
|
|
Spandidos Publications
8 publications, 1.85%
|
|
SAGE
7 publications, 1.62%
|
|
Hindawi Limited
7 publications, 1.62%
|
|
American Chemical Society (ACS)
6 publications, 1.39%
|
|
Oxford University Press
6 publications, 1.39%
|
|
Impact Journals
5 publications, 1.15%
|
|
Mary Ann Liebert
4 publications, 0.92%
|
|
Ovid Technologies (Wolters Kluwer Health)
4 publications, 0.92%
|
|
Bentham Science Publishers Ltd.
3 publications, 0.69%
|
|
Proceedings of the National Academy of Sciences (PNAS)
3 publications, 0.69%
|
|
American Society of Hematology
3 publications, 0.69%
|
|
American Society for Clinical Investigation
2 publications, 0.46%
|
|
The Company of Biologists
2 publications, 0.46%
|
|
American Society for Biochemistry and Molecular Biology
2 publications, 0.46%
|
|
American Association for Cancer Research (AACR)
2 publications, 0.46%
|
|
eLife Sciences Publications
2 publications, 0.46%
|
|
S. Karger AG
1 publication, 0.23%
|
|
The Royal Society
1 publication, 0.23%
|
|
Baishideng Publishing Group
1 publication, 0.23%
|
|
Laser Application in Medical Sciences Research Center
1 publication, 0.23%
|
|
Pensoft Publishers
1 publication, 0.23%
|
|
Federation of American Societies for Experimental Biology (FASEB)
1 publication, 0.23%
|
|
20
40
60
80
100
120
|
- We do not take into account publications without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Ma Bin, Hottiger M. O. Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation // Frontiers in Immunology. 2016. Vol. 7.
GOST all authors (up to 50)
Copy
Ma Bin, Hottiger M. O. Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation // Frontiers in Immunology. 2016. Vol. 7.
Cite this
RIS
Copy
TY - JOUR
DO - 10.3389/fimmu.2016.00378
UR - https://doi.org/10.3389/fimmu.2016.00378
TI - Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation
T2 - Frontiers in Immunology
AU - Ma Bin
AU - Hottiger, Michael O.
PY - 2016
DA - 2016/09/22
PB - Frontiers Media S.A.
VL - 7
PMID - 27713747
SN - 1664-3224
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2016_Ma Bin,
author = {Ma Bin and Michael O. Hottiger},
title = {Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation},
journal = {Frontiers in Immunology},
year = {2016},
volume = {7},
publisher = {Frontiers Media S.A.},
month = {sep},
url = {https://doi.org/10.3389/fimmu.2016.00378},
doi = {10.3389/fimmu.2016.00378}
}
Found error?
Found error?
Publisher
Journal
scimago Q1
SJR
1.868
CiteScore
9.8
Impact factor
5.7
ISSN
16643224
(Electronic)